- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01526642
Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients (NIVOLD)
August 21, 2017 updated by: University Hospital, Rouen
Home Non-invasive Ventilation Versus Long-term Oxygen Therapy in COPD Survivors of Acute Hypercapnic Respiratory Failure. A Multicenter Randomized Controlled Trial
Chronic Obstructive Pulmonary disease (COPD) patients with chronic hypercapnic respiratory failure are more likely to develop exacerbations.
Non-invasive ventilation has been proposed to treat acute respiratory failure but little information is available about the benefits of home non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure surviving an acute hypercapnic respiratory failure.
The purpose of this study is to determine whether home non-invasive ventilation can reduce recurrent acute hypercapnic respiratory failure in COPD patients who survived an episode of acute hypoxemic respiratory failure (AHRF) treated by Non-invasive ventilation (NIV).
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rouen, France, 76000
- CHU de Rouen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 18 years old
- COPD patients who survived after an episode of acute hypercapnic respiratory failure
- Patients weaned from ventilation (non invasive ventilation or mechanical ventilation) for acute episode since at least seven days with stable arterial blood gas since at least two days: PaCO2 > 55 mmHg and pH > 7.35
Exclusion Criteria:
- Age > 85 years old
- Non- COPD causes of respiratory failure
- Obstructive sleep apnea excluded by polysomnography
- Adverse psychosocial status
- Serious co-morbidity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Long Term Oxygen Therapy
|
|
|
Active Comparator: Non Invasive Ventilation
|
NIV during night
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Acute hypercapnic respiratory failure episode
Time Frame: up to 102 weeks
|
up to 102 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Death
Time Frame: 1 month and every 6 months during 2 years
|
1 month and every 6 months during 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
January 23, 2012
First Submitted That Met QC Criteria
February 3, 2012
First Posted (Estimate)
February 6, 2012
Study Record Updates
Last Update Posted (Actual)
August 22, 2017
Last Update Submitted That Met QC Criteria
August 21, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010/080/HP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Poitiers University HospitalCompletedBroncho Chronic Obstructive Pulmonary DiseaseFrance
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
Clinical Trials on Non Invasive Ventilation
-
Guy's and St Thomas' NHS Foundation TrustCompletedMotor Neurone Disease | Hypoxemia and/or HypercapniaUnited Kingdom
-
Centre Chirurgical Marie LannelongueCentre Hospitalier René Dubos; University Hospital, Bordeaux; University Hospital... and other collaboratorsCompletedRespiratory InsufficiencyFrance
-
Hamilton Health Sciences CorporationActive, not recruiting
-
Universidade Federal do Rio Grande do NorteCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Spaulding Rehabilitation HospitalCompletedSpinal Cord InjuryUnited States
-
University Hospital, MontpellierCompletedRespiratory Failure | Non Invasive Ventilation on Healthy VolunteerFrance
-
Sociedad Española de Neumología y Cirugía TorácicaCompletedObesity Hypoventilation Syndrome | Chronic Hypercapnic Respiratory FailureSpain
-
Postgraduate Institute of Medical Education and...Completed
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Completed
-
Fisher and Paykel HealthcareNot yet recruitingRespiratory Failure Requiring Non Invasive Ventilation